Gary A Johnson

Author PubWeight™ 8.01^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Surgical-pathological predictors of disease-free survival and risk groupings for IB2 cervical cancer: do the traditional models still apply?	Gynecol Oncol	2004	2.08
2	Carcinosarcoma of the ovary-a case series.	Gynecol Oncol	2005	1.03
3	Laparoscopic pelvic and paraaortic lymph node dissection in the obese.	Gynecol Oncol	2002	0.87
4	Preoperative predictors of positive margins after loop electrosurgical excisional procedure-Cone.	Gynecol Oncol	2006	0.85
5	A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?	Gynecol Oncol	2004	0.83
6	Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.	Gynecol Oncol	2004	0.83
7	A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies.	Cancer Chemother Pharmacol	2015	0.78
8	Outpatient implantation of a central venous access system in gynecologic oncology patients.	J Reprod Med	2003	0.77